NCT02057016View on ClinicalTrials.gov

Long-term Scheduled Therapy With Infliximab in Inflammatory Bowel Disease

CompletedOBSERVATIONAL
Enrollment

258

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Crohn's DiseaseUlcerative Colitis
Trial Locations (1)

00168

IBD Unit, Complesso Integrato Columbus, Catholic University of the Sacred Heart, Rome

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Catholic University of the Sacred Heart

OTHER

NCT02057016 - Long-term Scheduled Therapy With Infliximab in Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter